| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Medical Errors | 6 | 2021 | 201 | 1.90 | Why? |
| Defensive Medicine | 2 | 2018 | 8 | 1.51 | Why? |
| Medical Overuse | 2 | 2018 | 146 | 1.22 | Why? |
| Medication Errors | 2 | 2019 | 107 | 1.19 | Why? |
| Patient Safety | 8 | 2021 | 4885 | 1.18 | Why? |
| Patient Satisfaction | 5 | 2019 | 2517 | 0.81 | Why? |
| Quality Indicators, Health Care | 3 | 2019 | 580 | 0.75 | Why? |
| Truth Disclosure | 3 | 2021 | 196 | 0.75 | Why? |
| Pneumonia, Pneumococcal | 2 | 2018 | 251 | 0.74 | Why? |
| Keratosis, Actinic | 1 | 2018 | 54 | 0.73 | Why? |
| Primary Care Nursing | 1 | 2018 | 26 | 0.73 | Why? |
| Accidents, Occupational | 1 | 2018 | 46 | 0.72 | Why? |
| Headache | 2 | 2019 | 2257 | 0.72 | Why? |
| Isometric Contraction | 1 | 2017 | 19 | 0.71 | Why? |
| Muscle Fatigue | 1 | 2017 | 25 | 0.70 | Why? |
| Constipation | 1 | 2018 | 99 | 0.69 | Why? |
| Out-of-Hospital Cardiac Arrest | 9 | 2018 | 1047 | 0.65 | Why? |
| Electromyography | 2 | 2018 | 278 | 0.64 | Why? |
| Unnecessary Procedures | 1 | 2018 | 175 | 0.63 | Why? |
| Private Sector | 1 | 2018 | 262 | 0.62 | Why? |
| Irritable Bowel Syndrome | 1 | 2018 | 175 | 0.61 | Why? |
| Psychosocial Support Systems | 1 | 2020 | 710 | 0.55 | Why? |
| Hypothermia, Induced | 4 | 2018 | 176 | 0.54 | Why? |
| Health Personnel | 7 | 2021 | 29646 | 0.52 | Why? |
| Patient Participation | 1 | 2021 | 829 | 0.52 | Why? |
| Quality Assurance, Health Care | 1 | 2018 | 596 | 0.50 | Why? |
| Caregivers | 2 | 2018 | 3112 | 0.49 | Why? |
| Professional-Patient Relations | 1 | 2017 | 426 | 0.48 | Why? |
| Patient-Centered Care | 1 | 2021 | 860 | 0.48 | Why? |
| Health Care Surveys | 2 | 2018 | 2942 | 0.46 | Why? |
| Health Services | 1 | 2018 | 765 | 0.45 | Why? |
| Hospital Units | 1 | 2019 | 1017 | 0.45 | Why? |
| Central Nervous System | 1 | 2017 | 701 | 0.45 | Why? |
| Community Participation | 1 | 2018 | 605 | 0.44 | Why? |
| Quality of Health Care | 4 | 2020 | 1948 | 0.44 | Why? |
| Patient Preference | 1 | 2018 | 750 | 0.43 | Why? |
| Psychometrics | 1 | 2018 | 1269 | 0.43 | Why? |
| Primary Health Care | 6 | 2021 | 4839 | 0.41 | Why? |
| Public Health Practice | 1 | 2018 | 945 | 0.40 | Why? |
| General Practice | 1 | 2018 | 718 | 0.39 | Why? |
| Spain | 12 | 2021 | 15545 | 0.39 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 1261 | 0.38 | Why? |
| Qualitative Research | 6 | 2021 | 4337 | 0.36 | Why? |
| Home Care Services | 1 | 2018 | 1351 | 0.33 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.32 | Why? |
| Occupational Stress | 1 | 2020 | 2044 | 0.31 | Why? |
| Internet | 3 | 2020 | 6204 | 0.29 | Why? |
| Shock | 3 | 2018 | 1868 | 0.29 | Why? |
| Shock, Septic | 4 | 2019 | 1313 | 0.29 | Why? |
| Emotions | 1 | 2017 | 2418 | 0.28 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.26 | Why? |
| Occupational Diseases | 1 | 2018 | 2787 | 0.25 | Why? |
| Critical Illness | 5 | 2021 | 17281 | 0.25 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.24 | Why? |
| Pediatrics | 1 | 2018 | 2969 | 0.24 | Why? |
| Safety Management | 3 | 2021 | 1093 | 0.23 | Why? |
| Insurance | 1 | 2021 | 37 | 0.22 | Why? |
| Emergency Medical Services | 1 | 2018 | 3557 | 0.22 | Why? |
| Consensus Development Conferences as Topic | 1 | 2021 | 93 | 0.22 | Why? |
| Diet, Protein-Restricted | 1 | 2021 | 80 | 0.21 | Why? |
| Humans | 62 | 2021 | 930598 | 0.21 | Why? |
| Health Knowledge, Attitudes, Practice | 3 | 2018 | 8811 | 0.20 | Why? |
| H-Reflex | 1 | 2018 | 2 | 0.20 | Why? |
| Critical Care | 3 | 2018 | 14081 | 0.19 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.19 | Why? |
| Male | 38 | 2020 | 367725 | 0.19 | Why? |
| Endothelial Protein C Receptor | 1 | 2018 | 32 | 0.19 | Why? |
| Delphi Technique | 2 | 2021 | 1257 | 0.19 | Why? |
| Nurse-Patient Relations | 1 | 2021 | 168 | 0.18 | Why? |
| Phosphopyruvate Hydratase | 1 | 2018 | 47 | 0.18 | Why? |
| Ecuador | 1 | 2020 | 514 | 0.18 | Why? |
| S100 Calcium Binding Protein beta Subunit | 1 | 2018 | 63 | 0.18 | Why? |
| Health Services Administration | 1 | 2018 | 42 | 0.18 | Why? |
| Ankle | 1 | 2018 | 66 | 0.18 | Why? |
| Vibration | 1 | 2018 | 68 | 0.18 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.18 | Why? |
| Surveys and Questionnaires | 9 | 2021 | 43792 | 0.18 | Why? |
| Evoked Potentials, Motor | 1 | 2017 | 54 | 0.17 | Why? |
| Knee | 1 | 2017 | 35 | 0.17 | Why? |
| Midazolam | 1 | 2018 | 79 | 0.17 | Why? |
| Female | 35 | 2020 | 380317 | 0.17 | Why? |
| Proxy | 1 | 2017 | 32 | 0.17 | Why? |
| Anesthetics, Intravenous | 1 | 2018 | 98 | 0.17 | Why? |
| Adrenal Glands | 1 | 2018 | 98 | 0.17 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.16 | Why? |
| Cardiotoxicity | 1 | 2020 | 365 | 0.16 | Why? |
| Disclosure | 1 | 2021 | 423 | 0.16 | Why? |
| Respiratory Insufficiency | 4 | 2019 | 7301 | 0.16 | Why? |
| Personal Protective Equipment | 2 | 2021 | 15978 | 0.16 | Why? |
| Intensive Care Units | 11 | 2020 | 29594 | 0.16 | Why? |
| Fentanyl | 1 | 2018 | 142 | 0.16 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.16 | Why? |
| Polypharmacy | 1 | 2019 | 347 | 0.16 | Why? |
| Parenteral Nutrition | 1 | 2017 | 184 | 0.15 | Why? |
| Echinocandins | 1 | 2017 | 139 | 0.15 | Why? |
| Capillary Leak Syndrome | 1 | 2017 | 119 | 0.15 | Why? |
| Long Term Adverse Effects | 1 | 2017 | 119 | 0.15 | Why? |
| Colombia | 1 | 2020 | 1241 | 0.15 | Why? |
| Candidiasis, Invasive | 1 | 2017 | 107 | 0.15 | Why? |
| Propofol | 1 | 2018 | 172 | 0.15 | Why? |
| Physicians, Family | 1 | 2018 | 208 | 0.15 | Why? |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2018 | 235 | 0.15 | Why? |
| Prospective Studies | 13 | 2019 | 43301 | 0.15 | Why? |
| Noninvasive Ventilation | 2 | 2019 | 2329 | 0.14 | Why? |
| Health Plan Implementation | 1 | 2020 | 571 | 0.14 | Why? |
| Focus Groups | 1 | 2018 | 811 | 0.14 | Why? |
| Acute Disease | 4 | 2020 | 6029 | 0.14 | Why? |
| Oxygen Inhalation Therapy | 2 | 2019 | 3629 | 0.14 | Why? |
| Enteral Nutrition | 1 | 2017 | 320 | 0.14 | Why? |
| Review Literature as Topic | 1 | 2018 | 387 | 0.14 | Why? |
| Middle Aged | 29 | 2020 | 270681 | 0.14 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.14 | Why? |
| Troponin | 1 | 2020 | 1058 | 0.14 | Why? |
| Cross-Sectional Studies | 7 | 2021 | 53120 | 0.13 | Why? |
| Endotoxemia | 1 | 2015 | 143 | 0.13 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.13 | Why? |
| Quality-Adjusted Life Years | 1 | 2017 | 511 | 0.13 | Why? |
| Aged | 24 | 2019 | 215776 | 0.13 | Why? |
| Clinical Deterioration | 1 | 2018 | 473 | 0.13 | Why? |
| Dermatologists | 1 | 2018 | 435 | 0.13 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.12 | Why? |
| European Union | 1 | 2017 | 565 | 0.12 | Why? |
| Candidiasis | 1 | 2017 | 334 | 0.12 | Why? |
| Language | 1 | 2018 | 655 | 0.12 | Why? |
| Staphylococcus aureus | 1 | 2019 | 844 | 0.12 | Why? |
| Social Networking | 1 | 2019 | 737 | 0.12 | Why? |
| Health Facilities | 1 | 2020 | 1230 | 0.12 | Why? |
| Vasculitis | 1 | 2019 | 691 | 0.12 | Why? |
| Ventricular Dysfunction, Left | 1 | 2020 | 993 | 0.12 | Why? |
| Death, Sudden, Cardiac | 1 | 2017 | 522 | 0.12 | Why? |
| Sex Factors | 3 | 2018 | 11014 | 0.12 | Why? |
| Organizational Policy | 1 | 2017 | 694 | 0.12 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.11 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.11 | Why? |
| Migraine Disorders | 1 | 2019 | 530 | 0.11 | Why? |
| Plasma Exchange | 1 | 2018 | 763 | 0.11 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.11 | Why? |
| Living Wills | 1 | 2010 | 7 | 0.11 | Why? |
| Right to Die | 1 | 2010 | 13 | 0.11 | Why? |
| Cardiopulmonary Resuscitation | 4 | 2017 | 1876 | 0.11 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.11 | Why? |
| Physician-Patient Relations | 1 | 2021 | 1266 | 0.10 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.10 | Why? |
| Myocardial Ischemia | 1 | 2017 | 781 | 0.10 | Why? |
| Diabetes Mellitus | 1 | 2012 | 8207 | 0.10 | Why? |
| Staphylococcal Infections | 1 | 2019 | 1099 | 0.10 | Why? |
| Flow Cytometry | 1 | 2018 | 2393 | 0.10 | Why? |
| Adult | 16 | 2021 | 244371 | 0.10 | Why? |
| Electrocardiography | 2 | 2020 | 3957 | 0.10 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.10 | Why? |
| Bipolar Disorder | 1 | 2018 | 744 | 0.10 | Why? |
| Delivery of Health Care, Integrated | 1 | 2021 | 1549 | 0.09 | Why? |
| Age Factors | 3 | 2019 | 21039 | 0.09 | Why? |
| Patient Education as Topic | 1 | 2019 | 1476 | 0.09 | Why? |
| Pharmacists | 1 | 2018 | 1246 | 0.09 | Why? |
| France | 6 | 2020 | 12074 | 0.09 | Why? |
| Publishing | 1 | 2018 | 990 | 0.09 | Why? |
| Schizophrenia | 1 | 2018 | 1018 | 0.08 | Why? |
| Physicians | 2 | 2021 | 4214 | 0.08 | Why? |
| Neurology | 1 | 2019 | 1613 | 0.08 | Why? |
| Uncertainty | 1 | 2018 | 1888 | 0.08 | Why? |
| Organ Dysfunction Scores | 3 | 2018 | 1475 | 0.08 | Why? |
| State Medicine | 1 | 2020 | 2847 | 0.08 | Why? |
| Echocardiography | 1 | 2020 | 3661 | 0.08 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.08 | Why? |
| Heart Diseases | 2 | 2020 | 3503 | 0.08 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.08 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.08 | Why? |
| Hypoxia | 2 | 2019 | 3626 | 0.08 | Why? |
| Antifungal Agents | 1 | 2017 | 1828 | 0.08 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.08 | Why? |
| Risk Factors | 7 | 2019 | 71621 | 0.07 | Why? |
| Resuscitation | 1 | 2011 | 638 | 0.07 | Why? |
| HMGB1 Protein | 1 | 2007 | 223 | 0.07 | Why? |
| Intubation, Intratracheal | 2 | 2019 | 3962 | 0.07 | Why? |
| Immunoglobulins, Intravenous | 1 | 2017 | 2705 | 0.07 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.07 | Why? |
| Fear | 1 | 2020 | 3607 | 0.07 | Why? |
| Periodicals as Topic | 1 | 2018 | 1492 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
| Mobile Applications | 1 | 2020 | 3032 | 0.07 | Why? |
| Prognosis | 5 | 2018 | 32490 | 0.07 | Why? |
| Toll-Like Receptor 4 | 1 | 2007 | 390 | 0.07 | Why? |
| Time-to-Treatment | 2 | 2018 | 5883 | 0.07 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.07 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.07 | Why? |
| Hospital Mortality | 5 | 2018 | 22087 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.06 | Why? |
| Body Mass Index | 1 | 2016 | 4306 | 0.06 | Why? |
| Paris | 2 | 2018 | 1287 | 0.06 | Why? |
| Family | 1 | 2017 | 2909 | 0.06 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.06 | Why? |
| Brazil | 1 | 2020 | 12582 | 0.06 | Why? |
| Registries | 3 | 2018 | 12327 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Referral and Consultation | 1 | 2019 | 4816 | 0.06 | Why? |
| Acidosis, Lactic | 1 | 2003 | 83 | 0.06 | Why? |
| Nurses | 1 | 2018 | 2285 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.06 | Why? |
| Vasoconstrictor Agents | 2 | 2017 | 714 | 0.06 | Why? |
| Venous Thrombosis | 1 | 2018 | 2739 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.06 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2003 | 309 | 0.05 | Why? |
| Respiration, Artificial | 4 | 2021 | 22116 | 0.05 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.05 | Why? |
| Europe | 1 | 2018 | 12702 | 0.05 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.05 | Why? |
| Nucleosides | 1 | 2003 | 221 | 0.05 | Why? |
| Percutaneous Coronary Intervention | 1 | 2017 | 3646 | 0.05 | Why? |
| Cefotaxime | 1 | 2019 | 31 | 0.05 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.05 | Why? |
| Methicillin | 1 | 2019 | 73 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.05 | Why? |
| Anti-Bacterial Agents | 2 | 2019 | 10083 | 0.05 | Why? |
| Clindamycin | 1 | 2019 | 59 | 0.05 | Why? |
| Shivering | 1 | 2018 | 3 | 0.05 | Why? |
| Sodium Oxybate | 1 | 2017 | 14 | 0.05 | Why? |
| Muscle Contraction | 1 | 2018 | 60 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.04 | Why? |
| Leg | 1 | 2019 | 142 | 0.04 | Why? |
| Length of Stay | 4 | 2017 | 11042 | 0.04 | Why? |
| Biomarkers | 5 | 2020 | 23361 | 0.04 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.04 | Why? |
| Apoptosis | 1 | 2007 | 2335 | 0.04 | Why? |
| Organ Size | 1 | 2018 | 384 | 0.04 | Why? |
| Specialization | 1 | 2021 | 432 | 0.04 | Why? |
| Posture | 1 | 2018 | 199 | 0.04 | Why? |
| Deep Sedation | 1 | 2018 | 121 | 0.04 | Why? |
| Catheterization | 1 | 2019 | 264 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Amputation | 1 | 2019 | 331 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Coma | 1 | 2018 | 204 | 0.04 | Why? |
| ROC Curve | 2 | 2018 | 6024 | 0.04 | Why? |
| Pharmacovigilance | 1 | 2020 | 501 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Obesity | 1 | 2016 | 7388 | 0.04 | Why? |
| Italy | 1 | 2020 | 38444 | 0.04 | Why? |
| Electric Countershock | 1 | 2018 | 284 | 0.04 | Why? |
| Inpatients | 1 | 2011 | 5161 | 0.04 | Why? |
| Azoles | 1 | 2017 | 185 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2018 | 88759 | 0.04 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.04 | Why? |
| APACHE | 1 | 2017 | 682 | 0.03 | Why? |
| Neoplasms | 2 | 2017 | 17251 | 0.03 | Why? |
| Survivors | 2 | 2017 | 2619 | 0.03 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.03 | Why? |
| Antithrombins | 1 | 2018 | 353 | 0.03 | Why? |
| Oximetry | 1 | 2019 | 658 | 0.03 | Why? |
| Benchmarking | 1 | 2018 | 627 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Depression | 1 | 2018 | 14116 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Wakefulness | 1 | 2018 | 598 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.03 | Why? |
| Editorial Policies | 1 | 2018 | 408 | 0.03 | Why? |
| Nose | 1 | 2019 | 1093 | 0.03 | Why? |
| Fluid Therapy | 1 | 2017 | 628 | 0.03 | Why? |
| Candida | 1 | 2017 | 425 | 0.03 | Why? |
| Attitude of Health Personnel | 1 | 2010 | 4741 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2017 | 48226 | 0.03 | Why? |
| Medical Audit | 1 | 2011 | 218 | 0.03 | Why? |
| Anti-HIV Agents | 1 | 2003 | 2209 | 0.03 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.02 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.02 | Why? |
| Health Expenditures | 1 | 2017 | 904 | 0.02 | Why? |
| Tertiary Care Centers | 2 | 2017 | 8248 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.02 | Why? |
| Anthracyclines | 1 | 2007 | 65 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Interviews as Topic | 1 | 2017 | 1952 | 0.02 | Why? |
| Risk Assessment | 1 | 2011 | 25439 | 0.02 | Why? |
| Coronary Angiography | 1 | 2017 | 2275 | 0.02 | Why? |
| Retrospective Studies | 5 | 2018 | 105322 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Clinical Protocols | 1 | 2018 | 2734 | 0.02 | Why? |
| Equipment and Supplies | 1 | 2011 | 440 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2016 | 6543 | 0.02 | Why? |
| Treatment Outcome | 3 | 2017 | 51732 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Communication | 1 | 2021 | 5206 | 0.02 | Why? |
| Carnitine | 1 | 2003 | 47 | 0.02 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.01 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Brain | 1 | 2019 | 5133 | 0.01 | Why? |
| Adolescent | 3 | 2019 | 86841 | 0.01 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.01 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.01 | Why? |
| Polymorphism, Genetic | 1 | 2007 | 1074 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.01 | Why? |
| Lactic Acid | 1 | 2003 | 393 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Health Status Disparities | 1 | 2017 | 4072 | 0.01 | Why? |
| Dendritic Cells | 1 | 2007 | 1330 | 0.01 | Why? |
| HIV Infections | 1 | 2003 | 11620 | 0.01 | Why? |
| Mitochondria | 1 | 2003 | 857 | 0.01 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2007 | 3550 | 0.01 | Why? |
| Mice | 1 | 2007 | 21357 | 0.01 | Why? |
| Cohort Studies | 1 | 2011 | 36005 | 0.01 | Why? |
| Comorbidity | 1 | 2011 | 34796 | 0.01 | Why? |
| Animals | 1 | 2007 | 78931 | 0.00 | Why? |